ICMR Joins Forces with Bill & Melinda Gates Foundation & NIH for research

New Delhi: Indian Council of Medical Research (ICMR), the apex body in India for health research, signed a Declaration of Intent (DoI) with the National Institute of Allergy and Infectious Diseases (NIAD) of the National Institutes of Health, USA and the Bill & Melinda Gates Foundation (BMGF).

This Declaration of Intent builds on an ongoing collaborative research and training program between India and US, including enhancement of research capacity. The Declaration of Intent was exchanged in the presence of US Ambassador Mr Kenneth I. Juster and Mr. Bill Gates, Co-Chair, Bill and Melinda Gates Foundation.

The collaboration will establish a research fellowship programme for young scientists in India and US to expand research that will advance discovery to improve clinical practice and benefit public health in both countries. The initial focus of this fellowship programme is intended to engage scientists in infectious disease and immunology research, with an emphasis on diseases that affect women and children.

During the event, which also marked the celebration of 108th Foundation day of ICMR, Mr Gates also presented ICMR Lifetime Achievement Award for Outstanding Achievement in Healthcare to three game-changers of the country in the field of Health: Dr Cyrus S. Poonawalla, Chairman and Managing Director, Serum Institute of India; Dr Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon India and Dr Prakash Baba Amte, Director, Lok Biradari Prakalp. The awardees have been recognized for their efforts in providing better health care to people in the country and globally through innovative diagnostics, cost-effective life-saving tools and increasing access to healthcare at the grassroots.

The Standard Treatment Workflows (STWs) of India developed with the goal of empowering primary, secondary and tertiary care physicians/surgeons towards achieving the goal of Universal Health Coverage were also released on the occasion by Mr. Bill Gates, Dr. V. K. Paul, Dr. Balram Bhargava & Dr. Indu Bhushan. STWs will facilitate the successful implementation of Ayushman Bharat in the country.

Commenting on the importance of the collaborative fellowship programme with NIH and BMGF, Prof (Dr.) Balram Bhargava, Secretary, Department of Health Research and Director General, ICMR said, “There are great benefits in investing in research, especially in areas of infectious diseases and immunology, which will help the world in combating some of the debilitating diseases of the world.  ICMR is aggressively working towards major advances in preventing, treating, and curing diseases. This collaboration will give us a boost in finding cures that will make lives healthy and productive, not only in India but across the world.”

Bill Gates, Co-Chair, BMGF said, “The Bill & Melinda Gates Foundation is committed to working collaboratively with the ICMR to provide support in development of solutions to some of the major health challenges facing India and the world”.

Related Posts

‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

Best in Class ‘Made in India’ Surgical Robot is proving Best Bet New Delhi: ‘Made in India’ best in class surgical robot SSiMantra is proving godsend for cancer patients in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Maharashtra FDA appoints 34 lab personnel for its Mumbai based drug testing lab

Maharashtra FDA appoints 34 lab personnel for its Mumbai based drug testing lab

Ayush export declines by 7.4% in first nine months of FY 26

Ayush export declines by 7.4% in first nine months of FY 26

Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

ICMR mandates clinical trials to focus on Indian demography, lifestyle

ICMR mandates clinical trials to focus on Indian demography, lifestyle

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report